期刊文献+

诊治系统性硬皮病导致的肝损害1例

Systemic Seleroderma Disease-related Hepatic Injury
下载PDF
导出
摘要 目的研究硬皮病(Systemic Seleroderma)导致肝损害至肝硬化的临床特征及其诊断和治疗。方法对1例硬皮病导致肝损害患者的病史、临床表现、实验室检查、诊断治疗经过以及近期疗效进行回顾性分析。结果患者为老年女性,临床表现为乏力、腹胀,有血管炎、截趾手术等病史,血IgG、球蛋白升高,ESR增快,血ANA1:320阳性,肝脏病理特点符合结缔组织病所致的小血管炎表现。经小剂量甲泼尼松龙治疗后,临床症状和实验室检查指标明显好转,近期疗效显著。结论对于硬皮病患者肝功异常的鉴别诊断应该想到硬皮病导致肝损害的可能,对于肝功能损害明显、常规保肝治疗无效的患者可应用小剂量糖皮质激素治疗。 Objective To present the clinical features and management of a patiant with Systemic Seleroderma (SSc) disease-related hepatic injury. Methods Data of one case with SSc-related hepatic injury, including the case history, clinical manifestations, laboratory findings, treatment and short-term effect were reviewed retrospectively. Results The patient was a-old-aged woman who presented with symptoms of fatigue, anorexia, ascitic. "blood vessel", amputaion. Laboratory findings showed elevated serumtransaminases, IgG and globulin levels,accelerated erythrocyte sedimentation rate,eosinophilia and high titer of antinuclear antibodies (1 : 320). Liver biopsy showed the features consistent with connective tissue diseases-related !bolyangitis. Both symptoms and laboratorytests improved significamtly after treatment with low-dose prednisone. Conclusion UCTD-related hepatic injury should be considered inthe differential diagnosis of connective tissue diseases with abnormal liver function tests. Low-dose prednisone was effective to improveboth symptoms and laboratory tests.
出处 《中国中医药现代远程教育》 2012年第9期98-99,共2页 Chinese Medicine Modern Distance Education of China
关键词 硬皮病 肝损害 糖皮质激素 Scleroderma Hepatic injury Glucocorticoid
  • 相关文献

参考文献3

二级参考文献23

  • 1李明.硬皮病[M]//王侠生,廖康煌.杨国亮皮肤病学.上海:上海科学技术出版社,2005:540-7.
  • 2Steen V D.Pregnancy in scleroderma[J].Rheum Dis Clin North Am,2007,33 (2):345-58.
  • 3Rokieki W,Dukalska M,Rubisz-Brzezifiska J,et al.Circulatory system in children with localized scleroderma[J].Pediatr Cardiol,1997,18(3):213 -7.
  • 4Allcock R J, Forrest I, Corris PA, et al. A study of the prevalence of systemic sclerosis in northeast England [J]. Rheumatology, 2004, 43 (5) :596-602.
  • 5Tan FK, Arnett FC. Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon [ J ]. Curr Opin Rheumatol, 2000, 12 (6) : 511-519.
  • 6Jacobsen S, Halberg P, Ullman S. Mortality and causes of death of 344- Danish patients with systemic sclerosis (scleroderma) [J]. BrJ Rheumatol, 1998,37(7) : 750-755.
  • 7Lekakis J, Mavrikakis M, Papamicheal C, et al. Short-termestrogen administration improves abnormal endothelial functionin women with systemic sclerosis and Raynaud' s phenomenon[J]. Am Heart J, 1998,136 (5) :905-912.
  • 8Choi JJ, Min DJ, Cho ML, et al. Elevated vascular endothelial growth factor in systemic sclerosis [ J ]. J Rheumatol, 2003,30(7) : 1529-1533.
  • 9Takagi K, Kawaguchi Y, Hara M, et al. Serum nitric oxide(NO) levels in systemic sclerosis patlents:correlatlon between NO levels and clinical features[J] .Clin Exp Imrnunol,2003,134(3):538-544.
  • 10Young-Min SA, Beeton C, Laughton R, et al. Serum TMP-1, TMP-2 and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon and in normal controls [ J]. Ann Rheum Dis, 2001,60(9):846- 851.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部